ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.785,64
-0,69%
S&P 500
5.319,09
0,23%
US Dollar vs BRL
5,1533
0,01%
Bitcoin
68.135,19
-1,40%
Brent Oil
81,565
0,04%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Clementia Pharmaceuticals Inc. (CMTA)

  7. Clementia Pharmaceuticals Inc. (CMTA) Notícias

CMTA

Clementia Pharmaceuticals Inc. (CMTA)

Clementia Pharmaceuticals Inc.
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CMTA
DataHoraFonteTítuloCódigoCompanhia
15/08/201909:30GlobeNewswire Inc.Accomplished Financial Executive, Steve Forte, Joins Profound Medical’s BoardNASDAQ:CMTAClementia Pharmaceuticals Inc.
29/04/201909:28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMTAClementia Pharmaceuticals Inc.
19/04/201907:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CMTAClementia Pharmaceuticals Inc.
18/04/201910:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CMTAClementia Pharmaceuticals Inc.
18/04/201909:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMTAClementia Pharmaceuticals Inc.
18/04/201909:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CMTAClementia Pharmaceuticals Inc.
18/04/201909:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
11/04/201913:00GlobeNewswire Inc.Clementia Pharmaceuticals Inc. Announces Receipt of Final Court Approval for Plan of Arrangement With Ipsen S.A.NASDAQ:CMTAClementia Pharmaceuticals Inc.
09/04/201913:29GlobeNewswire Inc.Clementia Pharmaceuticals Inc. Shareholders Approve Plan of Arrangement With Ipsen S.A.NASDAQ:CMTAClementia Pharmaceuticals Inc.
29/03/201918:09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CMTAClementia Pharmaceuticals Inc.
13/03/201908:24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMTAClementia Pharmaceuticals Inc.
07/03/201916:59PR Newswire (US)Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
07/03/201915:25PR Newswire (Canada)Clementia Pharmaceutiques Inc. obtient une ordonnance provisoire pour la transaction proposée avec Ipsen S.A. et conclut des...NASDAQ:CMTAClementia Pharmaceuticals Inc.
07/03/201915:00PR Newswire (US)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
01/03/201918:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMTAClementia Pharmaceuticals Inc.
01/03/201916:15PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Clementia Pharmaceuticals, Inc.NASDAQ:CMTAClementia Pharmaceuticals Inc.
26/02/201908:30GlobeNewswire Inc.Clementia Announces Cancellation of Fourth Quarter and Year-End 2018 Financial Results and Conference CallNASDAQ:CMTAClementia Pharmaceuticals Inc.
25/02/201903:00Business WireIpsen to Acquire Clementia Pharmaceuticals to Significantly Boost Rare Disease PortfolioNASDAQ:CMTAClementia Pharmaceuticals Inc.
25/02/201903:00Business WireIpsen annonce l’acquisition de Clementia Pharmaceuticals et renforce son portefeuille dans les Maladies RaresNASDAQ:CMTAClementia Pharmaceuticals Inc.
20/02/201908:30GlobeNewswire Inc.Clementia Announces Date of Fourth Quarter and Full Year 2018 Results and Presentation at 8th Annual SVB Leerink Global Healt...NASDAQ:CMTAClementia Pharmaceuticals Inc.
13/02/201919:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CMTAClementia Pharmaceuticals Inc.
13/02/201912:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMTAClementia Pharmaceuticals Inc.
12/02/201912:34Edgar (US Regulatory)Schedule 13gNASDAQ:CMTAClementia Pharmaceuticals Inc.
11/02/201909:30GlobeNewswire Inc.Clementia Granted Rare Pediatric Disease Designation by FDA for Palovarotene for Fibrodysplasia Ossificans ProgressivaNASDAQ:CMTAClementia Pharmaceuticals Inc.
30/11/201812:00GlobeNewswire Inc.Clementia Announces the Departure of Chief Commercial OfficerNASDAQ:CMTAClementia Pharmaceuticals Inc.
21/11/201809:30GlobeNewswire Inc.Clementia to Present at the Evercore ISI HealthCONx ConferenceNASDAQ:CMTAClementia Pharmaceuticals Inc.
07/11/201809:30GlobeNewswire Inc.Clementia Reports Third Quarter 2018 Operating Results and Pipeline UpdatesNASDAQ:CMTAClementia Pharmaceuticals Inc.
30/10/201817:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CMTAClementia Pharmaceuticals Inc.
29/10/201822:21GlobeNewswire Inc.Clementia Announces Pricing of Public Offering of Common SharesNASDAQ:CMTAClementia Pharmaceuticals Inc.
29/10/201817:01GlobeNewswire Inc.Clementia Announces Proposed Public Offering of Common SharesNASDAQ:CMTAClementia Pharmaceuticals Inc.
 Apresentando as notícias mais relevantes sobre:NASDAQ:CMTA

Seu Histórico Recente

BOV
S1NP34Q
Synopsis
NASDAQ
ABAJWXX
Hsbc Bank Usa Na Capped ...
NYSE
SYD
Sybron Dental
BOV
R1FC34
Regions Financial
USOTC
BMOLF
Bank of Montreal (PK)
BIT
P1WFE6
NLBNPIT1WFE6 20991231 29...
COIN
BREEDUST
BreederDAO
NYSE
MYG
Maytag
BOV
BBDC3Q
BRADESCO ON
NASDAQ
ESLRD
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados